Journal of Anaesthesiology Clinical Pharmacology

REVIEW ARTICLE
Year
: 2019  |  Volume : 35  |  Issue : 4  |  Page : 434--440

Anesthetic considerations for stereotactic electroencephalography implantation


Chakrabarti Rajkalyan1, Anurag Tewari2, Shilpa Rao3, Rafi Avitsian4 
1 Department of Anesthesiology, Newham University Hospital, Barts Health NHS Trust, London
2 DBS and IONM, Evokes LLC, Mason, USA
3 Department of Neuro-Anesthesiology, Yale School of Medicine and Yale-New Haven Hospital, CT, USA
4 Department of of Anesthesiology, Cleveland Clinic Foundation, Cleveland, Ohio, USA

Correspondence Address:
Dr. Chakrabarti Rajkalyan
Newham University Hospital, Barts Health NHS Trust, London

The refractory seizures have significant impact on the quality of life and increase long term neurologic and non-neurologic complications. Implantation of Stereotactic Electroencephalography (SEEG) leads is one of the newer surgical techniques intended to localize seizure foci with higher accuracy than the conventional methods. Most of the commonly utilized anesthetic agents depress EEG waveforms affecting intra operative monitoring during these surgeries. Hence, the anesthetic goals include a stable induction and maintenance with agents which have minimal effect on EEG. This article discusses the peri-operative considerations of multiple anti-epileptic medications, recent advances in anesthetic management, and important post-operative concerns.


How to cite this article:
Rajkalyan C, Tewari A, Rao S, Avitsian R. Anesthetic considerations for stereotactic electroencephalography implantation.J Anaesthesiol Clin Pharmacol 2019;35:434-440


How to cite this URL:
Rajkalyan C, Tewari A, Rao S, Avitsian R. Anesthetic considerations for stereotactic electroencephalography implantation. J Anaesthesiol Clin Pharmacol [serial online] 2019 [cited 2020 Jan 26 ];35:434-440
Available from: http://www.joacp.org/article.asp?issn=0970-9185;year=2019;volume=35;issue=4;spage=434;epage=440;aulast=Rajkalyan;type=0